港股異動丨重卡股走強 2月重卡銷6.8萬輛增15% 終結“21個月連降”
格隆匯3月2日丨港股市場中國重汽升2.51%,中集車輛升約2%;A股市場中國重汽大升逾7%。據第一商用車網初步掌握的數據,2023年2月份,我國重卡市場大約銷售6.8萬輛左右(開票口徑,包含出口和新能源),環比2023年1月上升50%,比上年同期的5.94萬輛增長15%,淨增加約9000輛。終結了重卡市場自2021年5月份以來的連續下降勢頭,具有里程碑式的重要意義。在此之前,重卡市場已經是連續21個月下滑,市場銷量異常慘烈。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.